US Stock MarketDetailed Quotes

APVO Aptevo Therapeutics

Watchlist
  • 4.410
  • -0.120-2.65%
Close Dec 20 16:00 ET
  • 4.510
  • +0.100+2.26%
Post 20:01 ET
2.21MMarket Cap-0.01P/E (TTM)

Aptevo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
-74.67%3.11M
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
-74.67%3.11M
--0
Cost of revenue
Gross profit
Operating expense
-20.55%5.21M
-26.34%6.02M
-9.97%6.98M
-9.06%28.88M
-16.92%6.38M
-15.71%6.56M
8.15%8.18M
-11.11%7.76M
-5.75%31.76M
-0.27%7.68M
Selling and administrative expenses
-21.09%2.11M
-12.33%2.38M
-9.95%3.23M
-15.15%11.77M
-7.21%2.79M
-19.14%2.67M
-26.54%2.72M
-7.02%3.59M
-5.61%13.87M
-4.81%3.01M
-General and administrative expense
-21.09%2.11M
-12.33%2.38M
-9.95%3.23M
-15.15%11.77M
-7.21%2.79M
-19.14%2.67M
-26.54%2.72M
-7.02%3.59M
-5.61%13.87M
-4.81%3.01M
Research and development costs
-20.17%3.1M
-33.30%3.64M
-9.98%3.75M
-4.33%17.11M
-23.17%3.59M
-13.18%3.89M
41.32%5.46M
-14.34%4.17M
-5.85%17.88M
2.88%4.67M
Operating profit
20.55%-5.21M
26.34%-6.02M
9.97%-6.98M
-0.83%-28.88M
16.92%-6.38M
15.71%-6.56M
-8.15%-8.18M
-38.23%-7.76M
-33.84%-28.64M
-90.20%-7.68M
Net non-operating interest income expense
Other net income (expense)
-50.66%112K
-38.70%141K
-98.45%149K
-71.31%10.23M
-92.54%188K
1,008.00%227K
-99.35%230K
523.28%9.58M
545.24%35.66M
198.59%2.52M
Special income (charges)
--0
--0
--0
--9.65M
--0
--0
--0
--9.65M
--0
--0
-Gain on sale of property,plant,equipment
--0
--0
--0
--9.65M
--0
--0
--0
--9.65M
--0
--0
Other non- operating income (expenses)
-50.66%112K
-38.70%141K
322.39%149K
-98.38%578K
-92.54%188K
1,008.00%227K
-99.35%230K
97.04%-67K
545.24%35.66M
198.59%2.52M
Income before tax
19.47%-5.1M
25.98%-5.88M
-474.06%-6.83M
-365.90%-18.65M
-20.01%-6.2M
18.89%-6.33M
-128.53%-7.95M
123.20%1.83M
123.85%7.01M
21.74%-5.16M
Income tax
Net income
19.47%-5.1M
25.98%-5.88M
-346.45%-6.83M
-316.91%-17.41M
-27.17%-5.9M
17.14%-6.33M
-128.38%-7.95M
136.03%2.77M
128.21%8.03M
25.99%-4.64M
Net income continuous Operations
19.47%-5.1M
25.98%-5.88M
-474.06%-6.83M
-365.90%-18.65M
-20.01%-6.2M
18.89%-6.33M
-128.53%-7.95M
123.20%1.83M
123.85%7.01M
21.74%-5.16M
Net income discontinuous operations
--0
--0
--0
22.31%1.24M
-43.76%293K
--0
--0
431.46%946K
6.52%1.01M
60.31%521K
Minority interest income
Net income attributable to the parent company
19.47%-5.1M
25.98%-5.88M
-346.45%-6.83M
-316.91%-17.41M
-27.17%-5.9M
17.14%-6.33M
-128.38%-7.95M
136.03%2.77M
128.21%8.03M
25.99%-4.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.47%-5.1M
25.98%-5.88M
-346.45%-6.83M
-316.91%-17.41M
-27.17%-5.9M
17.14%-6.33M
-128.38%-7.95M
136.03%2.77M
128.21%8.03M
25.99%-4.64M
Basic earnings per share
97.83%-17.76
-36.20%-2.72K
-157.25%-368.15
-190.45%-2.31K
68.08%-493.6444
66.42%-819.92
-121.97%-2K
125.48%643.06
125.86%2.56K
25.20%-1.55K
Diluted earnings per share
97.83%-17.76
-36.20%-2.72K
-157.25%-368.15
-190.45%-2.31K
68.08%-493.6444
66.42%-819.92
-121.97%-2K
125.48%643.06
125.86%2.56K
25.20%-1.55K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 00000000-74.67%3.11M0
Operating revenue --0--0--0--0--0--0--0--0-74.67%3.11M--0
Cost of revenue
Gross profit
Operating expense -20.55%5.21M-26.34%6.02M-9.97%6.98M-9.06%28.88M-16.92%6.38M-15.71%6.56M8.15%8.18M-11.11%7.76M-5.75%31.76M-0.27%7.68M
Selling and administrative expenses -21.09%2.11M-12.33%2.38M-9.95%3.23M-15.15%11.77M-7.21%2.79M-19.14%2.67M-26.54%2.72M-7.02%3.59M-5.61%13.87M-4.81%3.01M
-General and administrative expense -21.09%2.11M-12.33%2.38M-9.95%3.23M-15.15%11.77M-7.21%2.79M-19.14%2.67M-26.54%2.72M-7.02%3.59M-5.61%13.87M-4.81%3.01M
Research and development costs -20.17%3.1M-33.30%3.64M-9.98%3.75M-4.33%17.11M-23.17%3.59M-13.18%3.89M41.32%5.46M-14.34%4.17M-5.85%17.88M2.88%4.67M
Operating profit 20.55%-5.21M26.34%-6.02M9.97%-6.98M-0.83%-28.88M16.92%-6.38M15.71%-6.56M-8.15%-8.18M-38.23%-7.76M-33.84%-28.64M-90.20%-7.68M
Net non-operating interest income expense
Other net income (expense) -50.66%112K-38.70%141K-98.45%149K-71.31%10.23M-92.54%188K1,008.00%227K-99.35%230K523.28%9.58M545.24%35.66M198.59%2.52M
Special income (charges) --0--0--0--9.65M--0--0--0--9.65M--0--0
-Gain on sale of property,plant,equipment --0--0--0--9.65M--0--0--0--9.65M--0--0
Other non- operating income (expenses) -50.66%112K-38.70%141K322.39%149K-98.38%578K-92.54%188K1,008.00%227K-99.35%230K97.04%-67K545.24%35.66M198.59%2.52M
Income before tax 19.47%-5.1M25.98%-5.88M-474.06%-6.83M-365.90%-18.65M-20.01%-6.2M18.89%-6.33M-128.53%-7.95M123.20%1.83M123.85%7.01M21.74%-5.16M
Income tax
Net income 19.47%-5.1M25.98%-5.88M-346.45%-6.83M-316.91%-17.41M-27.17%-5.9M17.14%-6.33M-128.38%-7.95M136.03%2.77M128.21%8.03M25.99%-4.64M
Net income continuous Operations 19.47%-5.1M25.98%-5.88M-474.06%-6.83M-365.90%-18.65M-20.01%-6.2M18.89%-6.33M-128.53%-7.95M123.20%1.83M123.85%7.01M21.74%-5.16M
Net income discontinuous operations --0--0--022.31%1.24M-43.76%293K--0--0431.46%946K6.52%1.01M60.31%521K
Minority interest income
Net income attributable to the parent company 19.47%-5.1M25.98%-5.88M-346.45%-6.83M-316.91%-17.41M-27.17%-5.9M17.14%-6.33M-128.38%-7.95M136.03%2.77M128.21%8.03M25.99%-4.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.47%-5.1M25.98%-5.88M-346.45%-6.83M-316.91%-17.41M-27.17%-5.9M17.14%-6.33M-128.38%-7.95M136.03%2.77M128.21%8.03M25.99%-4.64M
Basic earnings per share 97.83%-17.76-36.20%-2.72K-157.25%-368.15-190.45%-2.31K68.08%-493.644466.42%-819.92-121.97%-2K125.48%643.06125.86%2.56K25.20%-1.55K
Diluted earnings per share 97.83%-17.76-36.20%-2.72K-157.25%-368.15-190.45%-2.31K68.08%-493.644466.42%-819.92-121.97%-2K125.48%643.06125.86%2.56K25.20%-1.55K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List